Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vertex Pharmaceuticals (NQ: VRTX ) 519.21 +16.76 (+3.34%) Streaming Delayed Price Updated: 1:54 PM EST, Nov 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Vertex Pharmaceuticals < Previous 1 2 ... 6 7 8 9 10 11 12 13 14 ... 53 54 Next > 3 Unstoppable Stocks You Can Buy Now Without Any Hesitation March 17, 2024 There's no need for delays in buying these great stocks. Via The Motley Fool Forget Tesla, Buy This Magnificent Healthcare Stock Instead March 17, 2024 Vertex Pharmaceuticals already has a fantastic business, and it could get much bigger in the future. Via The Motley Fool Missed Out on Eli Lilly? 3 Healthcare Stocks With Big Catalysts on the Horizon. March 09, 2024 Good news could be in store for all three of these drugmakers. Via The Motley Fool Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 15 Years March 08, 2024 Via Benzinga The Top 3 Biotech Stocks to Buy in March 2024 March 06, 2024 Although the biotech sector puts the benefits and risks in plain sight, three top biotech stocks to buy shine for investors. Via InvestorPlace 3 Biopharma Stocks You Don't Want to Miss in the New Bull Market March 05, 2024 All three have exciting programs on the way. Via The Motley Fool $100 Invested In This Stock 15 Years Ago Would Be Worth $1,500 Today February 27, 2024 Via Benzinga Game Changers: 3 Biotech Stocks That Could Be Multibaggers in the Making March 05, 2024 These three companies represent the world of biotech stocks and offer a unique blend of high risk and potentially high reward. Via InvestorPlace Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits March 04, 2024 Given recent industry performance, the enthusiasm investors have for biotech stocks to buy is low. But these three companies seem promising. Via InvestorPlace ChatGPT Stock Predictions: 3 Biotech Companies the AI Bot Thinks Have 10X Potential March 04, 2024 Here are three ChatGPT stock predictions for the most unpredictable of biotech stocks that might just have 10x potential. Via InvestorPlace Topics Artificial Intelligence Exposures Artificial Intelligence Why Editas Medicine Stock Soared as Much as 42% Higher This Week March 02, 2024 The clinical-stage genome editing company dropped a couple of important announcements for shareholders. Via The Motley Fool 3 Magnificent Growth Stocks to Buy in March March 02, 2024 These three stocks have two important common denominators: the same industry and tremendous growth prospects. Via The Motley Fool Apple Sinks After Wall Street Titan Pulls Magnificent 7 Stock From Conviction List March 01, 2024 Goldman Sachs is removing Apple from its Conviction List of buy-rated stocks. Looking at the potential reasons why and who replaced the tech giant. Via Benzinga These 4 Stocks Are the "Magnificent Seven" of Healthcare March 01, 2024 Their growth trajectories aren't as meteoric, but they're still notable. Via The Motley Fool Could These 3 Companies Headline a "Magnificent Seven" of Biotech Stocks? February 29, 2024 These stocks meet many of the criteria long-term investors look for. Via The Motley Fool Beam Rockets 27%, Hitting A Year High, On Its Efforts To Take On Crispr's New Gene-Editing Drug February 27, 2024 Both companies are working on treatments for genetic disorders. Via Investor's Business Daily 3 Biotech Stocks Bound to Blast Off By 2029 February 27, 2024 Biotech stocks are risky, but rewarding. These three biotechs specifically could see exponential gains in the coming years. Via InvestorPlace bluebird bio: How to play LEAPS options for growth and income February 27, 2024 Gene-editing is making huge headlines in the medical sector stemming from the first FDA approval for a CRISPR/cas9 treatment for sickle cell disease SCD and TDT Via MarketBeat Exposures Product Safety Vertex Pharmaceuticals (VRTX) Should Remain Supported February 27, 2024 Vertex Pharmaceuticals Incorporated (VRTX), is a biotechnology company. It engages in developing & commercializing therapies for treating cystic fibrosis (CF). Via Talk Markets 3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow February 27, 2024 Vertex shares have climbed almost 50% over the past year. Via The Motley Fool Median Drug Prices For Rare Diseases Hit $300K In 2023, Report Highlights Lack of Clear Rationale Behind Escalating Drug Prices February 26, 2024 Latest pharmaceutical trends in the U.S. as drug prices surged 35% in 2023. Uncover insights into the industry's focus on rare diseases, escalating costs, and the impact on FDA-approved drugs. Via Benzinga Is CRISPR Therapeutics the NVIDIA of gene editing? February 26, 2024 CRISPR Therapeutics AG (NASDAQ: CRSP) made worldwide headlines when it and partner Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) received the first-ever FDA approv Via MarketBeat Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety The Ultimate Growth Stock to Buy With $1,000 Right Now February 26, 2024 The positives are many and the negatives are few with this high-flying stock. Via The Motley Fool 2 Stocks That Could Crush the Market in 2024 February 25, 2024 These companies aren't slowing down, and their addressable markets are widening. Via The Motley Fool Three S&P 500 Giants Lead This List Of Stocks Near Buy Points February 24, 2024 Watch these five stocks, but the market is slightly extended. Via Investor's Business Daily Topics Stocks Exposures US Equities Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On. February 23, 2024 Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy. Via Investor's Business Daily The Best Stocks to Invest $5,000 in Right Now February 23, 2024 These stocks could be huge winners for long-term investors. Via The Motley Fool 3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024 February 22, 2024 With new innovation and high demand, biotech stocks could offer some of the most explosive opportunities of the year. Via InvestorPlace 3 Secret Stocks to Double Your Money by 2028 February 22, 2024 Vertex Pharmaceuticals (VRTX), UiPath (PATH), and Science Applications International (SAIC) are 3 secret stocks to double your money by 2028. Via InvestorPlace Vertex to Participate in Upcoming Investor Conferences February 20, 2024 From Vertex Pharmaceuticals Incorporated Via Business Wire < Previous 1 2 ... 6 7 8 9 10 11 12 13 14 ... 53 54 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
